DSDobrin Svinarov

Dobrin Svinarov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dobrin Svinarov has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dynamics of Immunological and Biochemical Markers Depends on the Severity and Time after Symptoms Onset of COVID-19 – Single Centre Analysis

    by Anastasiya Mihaylova, Spaska Lesichkova, Maria Atanasova, Julieta Hristova, Veneta Grigorova, Nevena Gesheva, Dobrin Svinarov, Milena Velizarova, Elisaveta Naumova


  • Open Access

    #3750 SERUM AMYLOID A AS PROGNOSTIC MARKER FOR CKD AND NON-CKD COVID-19 PATIENTS ADMITTED TO THE EMERGENCY ROOM

    by Rumen Filev, Mila Cankova, Boris Bogov, Dobrin Svinarov, Julieta Hristova, Krasimir Kalinov, Lionel Rostaing

    Patients with chronic kidney disease (CKD) and a SARS-CoV-2 infection are at higher risk of developing acute kidney injury (AKI) and of mortality after hospital admission. Herein, we assessed whether serum amyloid A (SAA) was associated with outcomes (AKI and/or death). The study group included 160 patients: 70 Covid-19-positive CKD patients (eGFR 38oC. Overall, creatinine level on admission was elevated in 40% of cases; eGFR was 2 in 37.5% of patients. Mean value of eGFR on admission was 82.3 mL/min/1.73 m2 for the non-CKD Covid-19-positive group, 49.5 mL/min/1.73 m2 for the CKD Covid-19-positive group, 62.3 mL/min/1.73 m2 for the CKD patients without COVID-19, and 111.1 mL/min/1.73 m2 for the healthy control group. In total, three Covid-19 patients needed renal-replacement therapy: two patients from the CKD group and one from the non-CKD group. AKI occurred in 38 Covid-19 patients (23.7%). Of these, 31 had CKD (44.3% of the Covid-19 positive CKD patients). Overall, within our cohort of 160 patients, in-hospital mortality was 14.3% (23 patients): of these, 82.6% had AKI (19 patients). Overall, 100% of patients that did not survive Covid-19 also had CKD. We analyzed the levels of SAA across the groups. The reference limits considered for negative results were 300 pg/ml (82.6%), whilst the remainder had results >250 pg/mL. The other patients who survived the infection in our cohort had levels well below 200 pg/ml. When the patients with AKI and without AKI were compared on the basis of SAA, patients with AKI had significantly higher biomarker values (p- = 0.02). When compared across the four groups, no significant differences were found except when comparing the healthy control group with the other three groups, where there was significance of p<0.0001 in each comparison. We confirm that SAA was a reliable biomarker for predicting AKI in Covid-19 patients. It also acted as a predictor for a fatal outcome in patients with severely Covid-19 infection. In conclusion, SAA is a reliable marker, highly informative in the emergency department setting, enabling us to have an early prognosis for the outcome of the Covid-19 infection for the patients in our cohort.

  • Open Access

    Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitus

    by Milena Velizarova, Vesselina Yanachkova, Tzenka Boneva, Silva Giragosyan, Ivelina Mihaleva, Pavlina Andreeva-Gateva, Dobrin Svinarov, Ivanka Dimova


  • Open Access

    Use of indocyanine green for liver function assessment and its role in predicting the risk of postoperative liver failure

    by Elena Arabadzhieva, Sasho Bonev, Dimitar Bulanov, Dragomir Dardanov, Georgi Korukov, Zhivko Shavalov, Lilia Simonova, Evgeni Zhivkov, Dobrin Svinarov, Milena Velizarova, et al.

    Postoperative liver failure (POLF) is one of the most serious complications in abdominal surgery, as its appearance is often associated with an unfavorable outcome.OBJECTIVE: To investigate the role of Indocyanine Green (ICG) and Indocyanine Green Retention rate (ICG-R15) for assessment of liver function in order to predict the risk of POLF.MATERIAL AND METHODS: In 06.2021 – 11.2022, a prospective study was conducted, including 20 patients admitted in University Hospital "Alexandrovska" for malignant liver neoplasms. Liver function was assessed by static biochemical parameters and intravenous ICG administration (0.5 mg/kg), aiming to measure the residual blood concentration at the 15th minute (ICG-R15). The results and the probable correlation with clinico-morphological features were processed statistically.RESULTS AND DISCUSSION: The study included 13 men (65%) and 7 women (35%) with primary (5) and metastatic (15) liver tumors. 13 minor (15%, major liver interventions were not undertaken (p=0.001). In the ICG-R15 <15% group, regardless of major resection performed, POLF was not observed. The lack of significant deviations in static liver indicators with marked differences in ICGR15 clearly shows the need to combine methods for a precise liver function assessment. POLF was rapidly controlled due to consideration of the resection volume in context of ICG-R15.CONCLUSION: The ICG-R15 is an easy, safe, and valuable tool for assessing liver function and identifying patients at risk of POLF. Additional studies are needed, as the present study is initial for Bulgaria.

  • Open Access

    Editorial

    by Dobrin Svinarov, Ivanka Paskaleva, Milena Velizarova

    Dear Colleagues,It is our great pleasure to welcome you to the special supplement issue of Biotechnology & Biotechnological Equipment presenting the proceedings of the Joint XXVIII Balkan Clinical ...

  • Open Access

    A proposed Common Training Framework for Specialists in Laboratory Medicine under EU Directive 2013/55/EC (The Recognition of Professional Qualifications)

    by Gijsbert Wieringa, Josep Queraltó, Evgenija Homšak, Nuthar Jassam, Etienne Cavalier, Dobrin Svinarov, Jasna L Krleža, Spyroula Christou, Richard Pikner, Trine Rennebod Larsen, et al.

    European Union (EU) Directive 2013/55/EC (The Recognition of Professional Qualifications) allows Member States to decide on a common set of minimum knowledge, skills and competences that are needed to pursue a given profession through a Common Training Framework. To be adopted the framework must combine the knowledge, skills and competences of at least one third of the Member States. Professionals who have gained their qualifications under a Common Training Framework will be able to have these recognised automatically within the Union. The backbone of the European Federation of Clinical Chemistry and Laboratory Medicine’s (EFLM) proposed Common Training Framework for non-medical Specialists in Laboratory Medicine is outlined here. It is based on an Equivalence of Standards in education, training, qualifications, knowledge, skills, competences and the professional conduct associated with specialist practice. In proposing the recognition of specialist practice EFLM has identified 15 EU Member States able to meet Equivalence and in whom the profession and/or its training is regulated (an additional EU Commission requirement). The framework supports and contributes to the Directive’s enabling goals for increasing professional mobility, safeguarding consumers and ensuring a more equitable distribution of skills and expertise across the Member States. It represents EFLM’s position statement and provides a template for professional societies and/or competent authorities to engage with the EU Commission.


  • Open Access

    Vitamin D Status has no Influence on the Incidence of Recurrent Urinary Tract Infections after Kidney Transplantation

    by Jean Jeanov Filipov, Borelli Kirilov Zlatkov, Emil Paskalev Dimitrov, Dobrin A. Svinarov

    Introduction. Recurrent urinary tract infections (rUTIs) after kidney transplantation (KT) are associated with significant decrease in graft survival. There is a growing body of evidence for the pleiotropic effects of vitamin D (VD), including immunomodulatory and antibacterial effect. The number of studies on VD’s pleiotropic effects in kidney transplant recipients (KTRs) however is low. The aim of our study was to assess the influence of VD on the incidence of recurrent UTIs after KT. Methods. The KTRs were tested for 25-hydroxyvitamin D (25VD) between 1.05.2012 and 30.11.2012. Patients within 12 months of transplantation, performed parathyroidectomy, concomitant intake of calcineurin inhibittors and mTOR inhibitors, advanced liver disease and VD supplementation were excluded from the study. Recurrent UTIs were defined as more than 3 episodes of active UTI within the last 12 months of testing for 25VD. Statistical analysis was carried out with SPSS version 22.0 and included descriptive statistics, Mann-Whitney U test. Determination of total 25VD was performed by a validated LC-MS/MS method. Results. A total of 275 patients met the above-mentioned criteria (males 182, females 93). The mean 25VD in patients with rUTIs (n=14) was 51.41±25.17 nmol/L, whereas in the group without rUTIs (n=261) the level was 60.35±23.29 nmol/L. After matching the two groups for seasonal factors (sampling for 25VD in July, August, September) and gender 169 patients were selected, and 11 were with rUTIs. No significant difference was detected in the 25VD level in the two groups (53.30±18.37 vs 49.08±21.04 nmol/L), p=0.342. Conclusions. Despite the higher 25VD in the KTRs without rUTIs, the difference between the two groups remained insignificant.